Form EFFECT Aegerion Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Aegerion Pharma (AEGR), QLT, Inc. (QLTI) will resume trading at 7:30am ET
June 15, 2016 7:11 AM EDTAegerion Pharma (NASDAQ: AEGR) and QLT, Inc. (NASDAQ: QLTI) will resume trading at 7:30am EDT.
... MoreQLT Inc. (QLTI), Aegerion Pharma (AEGR) Enter Strategic Merger Agreement
June 15, 2016 7:02 AM EDTAegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) and QLT Inc. (Nasdaq: QLTI) announced that they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly owned indirect subsidiary of QLT. Upon completion of the proposed merger, each outstanding share of Aegerion common stock will be exchanged for 1.0256 shares of QLT common stock. QLT plans to change its name upon the closing of the proposed transaction to Novelion Therapeutics Inc. (Novelion) and its common shares will trade on the NASDAQ Global Select Market and the Toronto Stock... More
